Dr Ximena Lopez joins Ethics Talk to discuss her article, coauthored with Antonio D. Garcia: “How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients.”
When confidential medical information can prevent a serious harm to a third party, the patient’s prima facie right to confidentiality must be balanced against the physician’s prima facie obligation to prevent serious harm to that third party.
AMA J Ethics. 2015;17(9):819-825. doi:
10.1001/journalofethics.2015.17.9.ecas1-1509.
Surgeons can have an impact on patients and communities that goes well beyond the operating room. This month on Ethics Talk, we discuss how the concept of "surgical justice" can help plastic surgeons deliver better care topatients and communities.
William M. Kuzon, Jr., MD, PhD, Emily Sluiter, and Katherine M. Gast, MD, MS
Plastic surgeons’ use of patient images on social media should conform to the American Society of Plastic Surgeons’ advertising and image use guidelines.
AMA J Ethics. 2018;20(4):403-413. doi:
10.1001/journalofethics.2018.20.4.sect1-1804.
AMA Journal of Ethics theme editor Arina Evgenievna Chesnokova, MPH, a third-year medical student at Baylor College of Medicine, interviewed Megan Sandel, MD, MPH about how physicians can establish partnerships with attorneys.
The question of whether and how results from personal genetic testing will motivate behavioral changes in consumers has only begun to receive the research attention it richly deserves.
Kyle B. Brothers, MD, PhD and Esther E. Knapp, MD, MBE
Direct-to-consumer genetic testing requires that physicians share decision making with patients, not order unnecessary tests or interventions, and refer to genetic specialists when necessary.
AMA J Ethics. 2018;20(9):E812-818. doi:
10.1001/amajethics.2018.812.
Rebekah Davis Reed, PhD, JD and Erik L. Antonsen, PhD, MD
Though the National Aeronautics and Space Administration’s collection of disaggregated genetic data for occupational surveillance and research raises numerous privacy concerns, the Genetic Information Nondiscrimination Act of 2008 allows genetic information to be used to develop personal pharmaceuticals.
AMA J Ethics. 2018;20(9):E849-856. doi:
10.1001/amajethics.2018.849.